Format

Send to

Choose Destination
J Am Soc Nephrol. 2012 Oct;23(10):1617-30. Epub 2012 Aug 2.

Treatment of idiopathic membranous nephropathy.

Author information

1
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA. waldmanm@niddk.nih.gov

Abstract

Exciting progress recently has been made in our understanding of idiopathic membranous nephropathy, as well as treatment of this disease. Here, we review important advances regarding the pathogenesis of membranous nephropathy. We will also review the current approach to treatment and its limitations and will highlight new therapies that are currently being explored for this disease including Rituximab, mycophenolate mofetil, and adrenocorticotropic hormone, with an emphasis on results of the most recent clinical trials.

PMID:
22859855
PMCID:
PMC3458460
DOI:
10.1681/ASN.2012010058
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center